Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124992183 | 12499218 | 3 | F | 20160406 | 20160825 | 20160627 | 20160902 | EXP | GB-MHRA-ADR 23481241 | GB-DRREDDYS-GER/UKI/16/0080728 | DR REDDYS | 67.00 | YR | F | Y | 80.00000 | KG | 20160902 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124992183 | 12499218 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | U | U | UNKNOWN | 75593 | |||||||||
| 124992183 | 12499218 | 2 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 6 WEEK COURSE ENDED AFTER 32 DAYS?5SA23(12/16) 5SA74(01/17) 5SF52(03/17) 5SL64(08/17) 5SK16 (05/17) | Y | U | 5SK16 | 0 | 120 | MG | SOLUTION FOR INJECTION | QD | |||
| 124992183 | 12499218 | 3 | C | ADCAL-D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 124992183 | 12499218 | 4 | C | LETROZOLE. | LETROZOLE | 1 | 0 | ||||||||||||
| 124992183 | 12499218 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 124992183 | 12499218 | 6 | C | ZOMORPH | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 124992183 | 12499218 | 7 | C | PERJETA | PERTUZUMAB | 1 | 0 | ||||||||||||
| 124992183 | 12499218 | 8 | C | HERCEPTIN | TRASTUZUMAB | 1 | ONGOING | 0 | 1 | DF | Q3W | ||||||||
| 124992183 | 12499218 | 9 | C | PERTUZUMAB | PERTUZUMAB | 1 | ONGOING | 0 | 1 | DF | Q3W | ||||||||
| 124992183 | 12499218 | 10 | C | DENOSUMAB | DENOSUMAB | 1 | 0 | 1 | DF | INJECTION | |||||||||
| 124992183 | 12499218 | 11 | C | DOCETAXEL. | DOCETAXEL | 1 | 0 | ||||||||||||
| 124992183 | 12499218 | 12 | C | DIURETIC | UNSPECIFIED INGREDIENT | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124992183 | 12499218 | 1 | Antibiotic therapy |
| 124992183 | 12499218 | 2 | Peripheral embolism |
| 124992183 | 12499218 | 3 | Product used for unknown indication |
| 124992183 | 12499218 | 4 | Product used for unknown indication |
| 124992183 | 12499218 | 5 | Product used for unknown indication |
| 124992183 | 12499218 | 6 | Product used for unknown indication |
| 124992183 | 12499218 | 7 | Product used for unknown indication |
| 124992183 | 12499218 | 8 | Breast cancer stage IV |
| 124992183 | 12499218 | 9 | Breast cancer stage IV |
| 124992183 | 12499218 | 10 | Bone disorder |
| 124992183 | 12499218 | 11 | Breast cancer stage IV |
| 124992183 | 12499218 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124992183 | 12499218 | HO |
| 124992183 | 12499218 | LT |
| 124992183 | 12499218 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124992183 | 12499218 | Blister | |
| 124992183 | 12499218 | Burning sensation | |
| 124992183 | 12499218 | Dermatitis | |
| 124992183 | 12499218 | Erythema multiforme | |
| 124992183 | 12499218 | Pain | |
| 124992183 | 12499218 | Protein deficiency | |
| 124992183 | 12499218 | Rash erythematous | |
| 124992183 | 12499218 | Scab | |
| 124992183 | 12499218 | Skin erosion | |
| 124992183 | 12499218 | Skin haemorrhage | |
| 124992183 | 12499218 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124992183 | 12499218 | 2 | 20160317 | 20160417 | 0 | |
| 124992183 | 12499218 | 3 | 20151016 | 0 | ||
| 124992183 | 12499218 | 11 | 20160210 | 0 |